This article provides a detailed, current overview of adoptive cell transfer (ACT) protocols for solid tumor immunotherapy, targeting researchers, scientists, and drug development professionals.
This article provides a comprehensive overview of advanced adoptive cell therapies (ACT) as a strategic solution for cancers resistant to conventional immunotherapies like checkpoint inhibitors.
This article provides a comprehensive analysis for researchers and drug development professionals on the emerging role of soluble programmed death-ligand 1 (sPD-L1) variants in resistance to immune checkpoint blockade.
This article provides a comprehensive guide for researchers and drug development professionals tackling the critical challenge of intra-tumoral heterogeneity in Cancer Stem Cell (CSC) analysis.
This article provides a comprehensive overview of the fibroblast-rich extracellular matrix as a critical physical and immunosuppressive barrier to T cell infiltration in solid tumors.
This article provides a detailed exploration of ATLAS-seq, a powerful single-cell RNA sequencing technology designed to precisely identify and characterize antigen-reactive T cells.
This article provides a comprehensive analysis of the synergistic mechanisms by which Aldehyde Dehydrogenase (ALDH) and ATP-binding cassette (ABC) transporters confer multidrug resistance (MDR) in cancer stem cells (CSCs).
This comprehensive guide provides researchers, scientists, and drug development professionals with an in-depth analysis of the ALDEFLUOR assay.
This article explores the transformative role of artificial intelligence and machine learning in predicting the evolution of treatment resistance in breast cancer.
This article provides a detailed exploration of Adeno-Associated Virus (AAV) vectors as delivery vehicles for CRISPR-Cas9 therapeutics in oncology, tailored for researchers and drug development professionals.